Status:

COMPLETED

Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)

Lead Sponsor:

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Conditions:

Malaria Infection

Eligibility:

All Genders

12-55 years

Phase:

PHASE2

Brief Summary

This study will evaluate the efficacy and safety of a single dose of M5717 plus pyronaridine tetraphosphate in clearing current Plasmodium falciparum infection and protecting against recurrent infecti...

Eligibility Criteria

Inclusion

  • Participants with Asymptomatic Plasmodium falciparum Malaria with no Fever or other sign of Acute Uncomplicated Malaria and, with Microscopic confirmation using Giemsa-stained thick film, and a Parasitemia of \>= 40 to \<= 10,000 Asexual Parasites/Microliter (μL) of Blood.
  • Axillary Temperature \< 37.0 degree Celcius (ºC) or oral/Tympanic/rectal Temperature\< 37.5ºC; without history of fever during the previous 48 hours.
  • Have a body weight \>= 45 kilogram (kg)
  • Participants capable of giving Signed Informed consent which includes Compliance with the requirements and restriction listed in the Informed consent form
  • Other Protocol defined Inclusion Criteria could apply

Exclusion

  • Participants with any disease requiring Chronic Treatment
  • Participants with any Preplanned surgery during the study
  • Participants with any previous Treatment with pyronaridine as part of a combination therapy during the last 3 months
  • Participants with any adequate Hematological, Hepatic, and renal function as defined in the Protocol
  • Other protocol defined Exclusion Criteria could apply

Key Trial Info

Start Date :

November 28 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 29 2024

Estimated Enrollment :

192 Patients enrolled

Trial Details

Trial ID

NCT05974267

Start Date

November 28 2023

End Date

December 29 2024

Last Update

October 8 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Groupe de Recherche Action en Sante (GRAS)

Ouagadougou, Burkina Faso

2

Kisumu County Referral Hospital

Kisumu, Kenya

3

MRC Unit The Gambia at LSHTM

Banjul, The Gambia

4

Ndola Teaching Hospital

Ndola, Zambia